ONE-SESSION MANAGEMENT OF CERVICAL INTRAEPITHELIAL NEOPLASIA - A SOLUTION FOR DEVELOPING-COUNTRIES - A PROSPECTIVE, RANDOMIZED TRIAL OF LEEP VERSUS LASER EXCISIONAL CONIZATION
C. Santos et al., ONE-SESSION MANAGEMENT OF CERVICAL INTRAEPITHELIAL NEOPLASIA - A SOLUTION FOR DEVELOPING-COUNTRIES - A PROSPECTIVE, RANDOMIZED TRIAL OF LEEP VERSUS LASER EXCISIONAL CONIZATION, Gynecologic oncology, 61(1), 1996, pp. 11-15
Six hundred thirty-nine patients with CIN on referral Pap were evaluat
ed cytocolposcopically at the first visit and decided whether to be tr
eated the same day or not. One hundred ninety-two patients (30%) were
considered negative. Follow-up evidenced later appearance of CIN in fi
ve of them. One hundred fifty-three (24%) were candidates for delayed
treatment due to conditions contraindicating same-day treatment. Two h
undred ninety-four patients (46%) were randomly allocated in LEEP (149
) or excisional laser (145) arms, and treated the same day under local
anesthesia. Both arms were comparable. There were three microinvasive
carcinomas diagnosed in the surgical specimen, LEEP was faster and pr
oduced less bleeding than laser, although required a mean of four slic
es to remove the lesion, Arterial hypertension after anesthetic infilt
ration was detected in 26% of cases. Two intraoperative and two delaye
d bleeders required surgery. The size of lesion and surgical defect we
re larger than those reported in the literature, Margins were involved
in 8 patients (2.7%). Only 4.7% (7/149) of patients randomized to LEE
P and 3.4% (5/145) with excisional laser had persistent or recurrent C
IN on follow-up. Factors predisposing to failure included depth of sur
gical defect, grade of lesion, and operator's expertise, With this app
roach, 69% of patients referred for cytology of CIN were adequately ma
naged in the first visit, which contrasts to classical management that
reaches the state of treatment in 30% of patients. LEEP appears to be
faster, less costly, and requires less expertise. Its use in conjunct
ion with adequate screening is recommended for developing countries. (
C) 1996 Academic Press, Inc.